IFNB1 and relapsing-remitting multiple sclerosis: However, IFNβ signaling can also suppress auto-immune responses, such as in relapsing remitting multiple sclerosis, where IFNβ is used therapeutically to slow disease progression [57], and Sulf2 may have deleterious effects in such contexts.